(Q74463189)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12118376%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

title

Loss of neurofibromatosis-1 and p19(ARF) cooperate to induce a multiple tumor phenotype (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12118376%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

author name string

Dana King

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12118376%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

Genyan Yang

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12118376%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

Mary Ann Thompson

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12118376%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

Scott W Hiebert

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12118376%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

language of work or name

English

0 references

publication date

1 July 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12118376%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12118376%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

volume

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12118376%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

issue

32

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12118376%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

page(s)

4978-4982

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12118376%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/sj.onc.1205632

11 November 2019

exact match

0 references

cites work

Targeted disruption of the neurofibromatosis type-1 gene leads to developmental abnormalities in heart and various neural crest-derived tissues

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205632

7 January 2021

Mouse models of tumor development in neurofibromatosis type 1

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205632

7 January 2021

Abnormal regulation of mammalian p21ras contributes to malignant tumor growth in von Recklinghausen (type 1) neurofibromatosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205632

7 January 2021

Disruption of the ARF-Mdm2-p53 tumor suppressor pathway in Myc-induced lymphomagenesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205632

7 January 2021

Haploinsufficiency for the neurofibromatosis 1 (NF1) tumor suppressor results in increased astrocyte proliferation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205632

7 January 2021

Neurofibromin GTPase-activating protein-related domains restore normal growth in Nf1-/- cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205632

7 January 2021

Genetic and biochemical evidence that haploinsufficiency of the Nf1 tumor suppressor gene modulates melanocyte and mast cell fates in vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205632

7 January 2021

Tumour predisposition in mice heterozygous for a targeted mutation in Nf1

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205632

7 January 2021

Tumor suppression at the mouse INK4a locus mediated by the alternative reading frame product p19ARF

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205632

7 January 2021

Loss of p16Ink4a confers susceptibility to metastatic melanoma in mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205632

7 January 2021

Nf1 deficiency causes Ras-mediated granulocyte/macrophage colony stimulating factor hypersensitivity and chronic myeloid leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205632

7 January 2021

Oncogenic ras activates the ARF-p53 pathway to suppress epithelial cell transformation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205632

7 January 2021

E2F-1 induces the stabilization of p53 but blocks p53-mediated transactivation.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205632

7 January 2021

Carcinogen-specific mutation and amplification of Ha-ras during mouse skin carcinogenesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205632

7 January 2021

Loss of p16Ink4a with retention of p19Arf predisposes mice to tumorigenesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205632

7 January 2021

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205632

1 reference

7 January 2021

Homozygous inactivation of the NF1 gene in bone marrow cells from children with neurofibromatosis type 1 and malignant myeloid disorders

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205632

7 January 2021

Mouse tumor model for neurofibromatosis type 1

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205632

7 January 2021

Quantitative effects of Nf1 inactivation on in vivo hematopoiesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205632

7 January 2021

Neurofibromin, a tumor suppressor in the nervous system

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205632

7 January 2021